Funding for this research was provided by:
Universität Zürich
Article History
Received: 29 September 2020
Revised: 23 March 2021
Accepted: 5 May 2021
First Online: 28 May 2021
Declarations
:
: RJU is currently employed by AstraZeneca BioPharmaceuticals R&D, Early CVRM, Gothenburg, Sweden and Cambridge, UK.